athlete’s heart vs. cardiomyopathy · athlete’s heart vs. cardiomyopathy linda d. gillam, md,...

48
10/2/2017 1 Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets No disclosures

Upload: others

Post on 22-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

1

Athlete’s Heart vs. CardiomyopathyLinda D. Gillam, MD, MPH, FASE

Chair, Department of Cardiovascular MedicineMedical Director, Cardiovascular Service Line

Former Team Cardiologist to the New York Jets

No disclosures

Page 2: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

2

Sports Cardiology at Morristown

Mat Martinez, MD, FACCDirector of Sports Cardiology

Official Cardiologist to the New York Jets

Questions asked of Echo

• Is increased wall thickness physiologic or pathologic?

• Are increased dimensions physiologic or pathologic?

• Is “reduced” function physiologic or pathologic?

Page 3: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

3

Is this normal or abnormal?

• Can this patient play sports (make a living, take a scholarship)?

• Does this patient need a defibrillator?

• Are there genetic/family implications to my decision?

• What is the prognosis?

Page 4: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

4

CAUSE OF SCA IN YOUNG ATHLETES(N=387, BASED ON AUTOPSY REPORTS

Causes of SCD

• Structural

• Electrical

• Other– Commotio cordis

– Myocarditis, dcm

Page 5: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

5

Corrado: J Am CollCard 2003

Thanks to Mat Martinez, MD

Page 6: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

6

Thanks to Mat Martinez, MD

The Changing Face of the American Athlete - Collegiate

Thanks to Mat Martinez, MD

Page 7: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

7

The Changing Face of the American Athlete - Masters

Atletes Come in All Shapes and Sizes

Page 8: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

8

Pay attention to age,gender,race, body size and sport specific norms!

Reminder

Non-myopathicconditions affect athletes too

– CAD

– HTN

– BAV etc

Page 9: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

9

Page 10: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

10

Exercise Physiology Basics

• Exercise requires oxygen

• Increased pulmonary oxygen uptake

• Increased cardiac output

• Increased peripheral oxygen extraction

Page 11: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

11

Exercise Physiology Basics

• Exercise requires oxygen

• Increased pulmonary oxygen uptake

• Increased cardiac output

• Increased peripheral oxygen extraction

Cardiac Output = HR X Stroke Volume

Stroke volume = End-diastolic volume minus End-systolic

volume*

* In the absence of valve regurgitation or intracardiac shunts

Page 12: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

12

• Cardiac output may increase 5-6 X with HR responsible for the majority of the change

• Max HR does not increase with exercise training (age-related)

• Stroke volume does increase with exercise training (resting and peak exercise)– SV increases because EDV ± ESV

2 Forms of Exercise Training(some overlap)

• Isotonic– Sustained increase in CO with normal or

reduced SVR

• Isometric– Increased SVR and normal or slightly

increased CO

Page 13: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

13

Athlete’s Heart

• Well recognized that repetitive physical exercise causes adaptive changes in cardiac structure and function

“Athlete’s Heart”

• Although historically some dispute as to whether changes were harmful, consensus is that this is a favorable adaptive response rather than pre-clinical disease

Athlete’s Heart

• Anatomic changes

• Functional changes

Page 14: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

14

Left Ventricular Response

• Increased cavity size• Increased wall thickness

– Generally associated with increased cavity size

– More pronounced in those who are large and Afro-Caribbean

• Morganroth hypothesis– Isotonic -> dilatation (eccentric LVH)– Isometric -> increased wall thickness

(concentric LVH)

Page 15: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

15

Similar Changes with RV

JASE 2017 Volume 30, Issue 9, Pages 845–858

Page 16: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

16

Wall thickness

Distribution of Maximal Left-Ventricular-Wall Thicknesses in the 947 Elite Athletes.

Pelliccia A et al. N Engl J Med 1991;324:295-301.

1.7% ≥ 1.3 cm

Pelliccia A et al. N Engl J Med 1991;324:295-301

Page 17: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

17

Gender Matters

Maron Circulation 2006 citing Pelliccia et al Ann Intern Med. 1999;130(1):23-31.

Race Matters

Page 18: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

18

Effect of specific sports training on LV cavity dimension or wall thickness in elite athletes, representing 27 different sporting disciplines.

Barry J. Maron, and Antonio Pelliccia Circulation. 2006;114:1633-1644

NFL 2011-2013

~ 10% ≥ 1.3 cm.

NFL data Courtesy of Dr Kovacs ACC 2013

Page 19: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

19

From: Athletic Cardiac Remodeling in US Professional Basketball Players: Engel et al

JAMA Cardiol. 2016;1(1):80-87.

~10% ≥ 1.3 cm.

Impact of Gender and Race

• Less remodeling in women (even with correcting smaller baseline heart sizes)

• More remodeling in blacks – LV wall thickness >12mm in 20% black

men vs 4 % whites

• Black women have thicker walls than white women

Page 20: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

20

Chamber dimensions

Pelliccia. Ann Intern Med. 1999;130(1):23-31.1309 elite athletes, all with EF >50%

LVEDD

Page 21: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

21

Abergel. J Am Coll Cardiol. 2004;44149

LVIDd >60m (51%)

Pro Cyclists LV chamber size

LV chamber size in the NBAFrom: Athletic Cardiac Remodeling in US Professional Basketball Players: Engel et alJAMA Cardiol. 2016;1(1):80-87.

All but 5 with normal EF > 50%

36%

Page 22: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

22

Gherardo Finocchiaro et al. JIMG 2017;10:965-972

Page 23: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

23

Gherardo Finocchiaro et al. JIMG 2017;10:965-972

Gherardo Finocchiaro et al. JIMG 2017;10:965-972

Page 24: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

24

Average training impulse (TRIMP) scores per month for all subjects over the training year.

Armin Arbab-Zadeh et al. Circulation. 2014;130:2152-2161

Page 25: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

25

Changes in left ventricular (LV) mass (left) and right ventricular (RV) mass (right) measured by magnetic resonance imaging every 3 months during the 1-year training program.

Armin Arbab-Zadeh et al. Circulation. 2014;130:2152-2161

Mean±SD changes in left ventricular end-diastolic volume (LVEDV; left) and right ventricular end-diastolic volume (RVEDV; middle) by magnetic resonance imaging measured every 3

months during the training program.

Armin Arbab-Zadeh et al. Circulation. 2014;130:2152-2161

Page 26: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

26

Systolic Function

LVEF/Systolic function

• Typically normal

• But may be borderline or mildly reduced (50-55%) leading to concern about dilated cardiomyopathy

• Role for stress echocardiography in establishing contractile reserve

• Strain also helpful

Page 27: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

27

Echocardiographic tissue Doppler imaging (A and C) and speckle-tracking radial strain analysis (B and D) in 2 different athletic patients presenting with left ventricular hypertrophy.

Baggish A L , Wood M J Circulation 2011;123:2723-2735

Atria

Page 28: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

28

Left atrium

• In Italian series >20% had enlarged left atria (as measured by AP diameter)– No volume data

• Questionable association with supraventricular arrhythmias

Page 29: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

29

Pelliccia. Ann Intern Med. 1999;130(1):23-31.

LA AP diameter

From Galderisi et al EACVI Recommendations

LA volumes

Page 30: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

30

Diastolic Function:Myopathy or Athlete’s Heart?

Diastolic Function

• Isotonic training– Enhanced relaxation

• Isometric training– Impaired or unchanged relaxation (less

well studied)

Page 31: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

31

• In athlete’s heart diastolic function is normal or super-normal

• In HCM, diastolic function is variably abnormal

Diastolic Function in the Athlete

• Increased early diastolic filling– E/A ratio > 1

• normal deceleration time – 100 -200 ms

• normal isovolumetric relaxation time – <100 ms.

Page 32: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

32

Galderisi et al European Heart Journal – Cardiovascular Imaging (2015) 16, 353

Diastolic Function in HCM• Decreased early diastolic filling

– E/A ratio <0.5

• Lengthened deceleration time

– >280 ms

• Ar-Ad > 30 ms

• Decreased annular e’

Page 33: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

33

Wall thickness = 1.2 cm

Decel time = 187 ms

Page 34: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

34

Page 35: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

35

Athlete’s Heart

IVS = 1.4, PW = 1.2

Page 36: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

36

Page 37: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

37

Hypertrophic CM

Page 38: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

38

When left atrial pressure is elevated

Journal of the American Society of Echocardiography 2011 24, 473-498DOI:

Diastolic abnormalities may be present prior to hypertrophy

Page 39: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

39

Individual data points showing septal and lateral Sa and Ea velocities at baseline and follow-up in both groups: the 12 subjects who had inherited the causal mutations for HCM and the 12

individuals in the control group.

Sherif F. Nagueh et al. Circulation. 2003;108:395-398

Page 40: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

40

Aorta

• Pathologic enlargement typically not encountered (>4 cm)

• Inconsistent data on impact of training on aortic root size

From: Athletic Cardiac Remodeling in US Professional Basketball PlayersEngel et al. JAMA Cardiol. 2016;1(1):80-87. doi:10.1001/jamacardio.2015.0252

Page 41: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

41

A word about complementary modalities

Page 42: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

42

EKG

Athlete’s EKG

Increased chamber size

Left ventricular hypertrophyIncomplete RBBB

Left atrial enlargementRight atrial enlargement

VagotoniaSinus bradycardiaSinus arrhythmiaFirst degree AVB

ST-elevationTall T waves

Page 43: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

43

MRI

• Assessment of LV/RV Mass, Dimensions

• Fibrosis

• Inflammation

• Pathognomonic findings in myopathies

Proposed Approach

Page 44: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

44

Galderisi EACVI Recommendation

Galderisi EACVI Recommendation

Galderisi EACVI Recommendation

Page 45: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

45

Sometimes even the experts are not sure

Deconditioning

Page 46: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

46

Impact of extreme endurance activity

Page 47: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

47

Figure 1. LV basal and apical circumferential and radial strains and LV longitudinal strains before (•) and after (○) the race.

Stéphane Nottin et al. Circ Cardiovasc Imaging. 2009;2:323-330

Sports CardiologistSports Cardiologist

Sports Medicine TeamATC / Ex Phys

Sports Medicine TeamATC / Ex Phys

EPEP CV ImagingCV ImagingAthleteCardiac Assess-

ment

Page 48: Athlete’s Heart vs. Cardiomyopathy · Athlete’s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular

10/2/2017

48

Take home messages

• Athlete’s heart may have altered anatomy and, to a lesser degree, function

• Published norms provide guidance but additional interventions (stress, deconditioning) may be essential

• Multimodality approach is essential– Advanced EKG interpretive skills

– MRI

• Meticulous echocardiography– Precise measurements

– Strain

– Stress echocardiography

• Specialized centers important